These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11760406)

  • 1. Growth and IGF-1 levels of children with familial Mediterranean fever on colchicine treatment.
    Savgan-Gürol E; Kasapçopur O; Hatemi S; Ercan O; Caliskan S; Sever L; Ozdogan H; Arisoy N
    Clin Exp Rheumatol; 2001; 19(5 Suppl 24):S72-5. PubMed ID: 11760406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of colchicine and disease severity on physical growth in children with familial Mediterranean fever.
    Yoldaş TÇ; Çakar N; Başaran Ö; Acar B; Uncu N; Çaycı FŞ
    Clin Rheumatol; 2016 Jun; 35(6):1603-7. PubMed ID: 26384820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial Mediterranean fever and growth: effect of disease severity and colchicine treatment.
    Zung A; Barash G; Zadik Z; Barash J
    J Pediatr Endocrinol Metab; 2006 Feb; 19(2):155-60. PubMed ID: 16562589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of colchicine on physical growth in children with familial mediterranean fever.
    Ozçakar ZB; Kadioğlu G; Siklar Z; Kavaz A; Nur Aksanal F; Berberoğlu M; Ekim M; Ocal G; Yalçinkaya F
    Eur J Pediatr; 2010 Jul; 169(7):825-8. PubMed ID: 20016916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth in familial mediterranean fever: effect of attack rate, genotype and colchicine treatment.
    Türkmen M; Soylu OB; Kasap B; Güneş S; Tüfekçi O; Soylu A; Erçal D; Kavukçu S
    J Pediatr Endocrinol Metab; 2008 Aug; 21(8):789-92. PubMed ID: 18825879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of hearing in pediatric familial Mediterranean fever patients during attack period and attack-free period.
    Salimov A; Akyol U; Cildir B; Batu ED; Ozen S
    Int J Pediatr Otorhinolaryngol; 2019 Apr; 119():185-192. PubMed ID: 30743166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of various cardiac autonomic indices in patients with familial Mediterranean fever on colchicine treatment.
    Canpolat U; Dural M; Aytemir K; Akdoğan A; Kaya EB; Sahiner L; Yalçin U; Canpolat AG; Calgüneri M; Kabakçi G; Tokgözoğlu L; Oto A
    Auton Neurosci; 2012 Apr; 167(1-2):70-4. PubMed ID: 22104493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubular functions in familial Mediterranean fever.
    Akkuş S; Calişkan S; Kasapçopur O
    Turk J Pediatr; 2002; 44(4):317-20. PubMed ID: 12458807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
    Eroglu FK; Beşbaş N; Topaloglu R; Ozen S
    Rheumatol Int; 2015 Oct; 35(10):1733-7. PubMed ID: 26001859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine immune system in familial Mediterranean fever.
    Topaloğlu R; Bilginer Y; Alikaşifoğlu A; Ozaltin F; Beşbaş N; Ozen S; Bakkaloğlu A
    Turk J Pediatr; 2010; 52(6):588-93. PubMed ID: 21428190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anemia of familial Mediterranean fever disease.
    Celkan T; Celik M; Kasapçopur O; Ozkan A; Apak H; Ocak S; Arisoy N; Yildiz I
    Pediatr Hematol Oncol; 2005 Dec; 22(8):657-65. PubMed ID: 16251171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased vitamin D levels in children with familial Mediterranean fever.
    Anık A; Catlı G; Makay B; Abacı A; Küme T; Unsal E; Böber E
    Int J Rheum Dis; 2014 Mar; 17(3):321-6. PubMed ID: 24410734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of sleep problems in children with familial Mediterranean fever.
    Makay B; Kiliçaslan SK; Anik A; Bora E; Bozkaya Ö; Çankaya T; Ünsal E
    Int J Rheum Dis; 2017 Dec; 20(12):2106-2112. PubMed ID: 24641439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colchicine treatment in children with familial Mediterranean fever.
    Ozkaya N; Yalçinkaya F
    Clin Rheumatol; 2003 Oct; 22(4-5):314-7. PubMed ID: 14579163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF?
    Terekeci HM; Oktenli C; Ozgurtas T; Nalbant S; Top C; Celik S; Tapan S; Kucukardali Y; Sanisoglu YS; Solmazgul E; Sahan B; Sayan O
    J Rheumatol; 2008 Oct; 35(10):2024-9. PubMed ID: 18785307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial stiffness in Familial Mediterranean Fever: correlations with disease-related parameters and colchicine treatment.
    Sgouropoulou V; Stabouli S; Trachana M
    Clin Rheumatol; 2019 Sep; 38(9):2577-2584. PubMed ID: 31127463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of colchicine on immunoregulatory abnormalities in familial Mediterranean fever.
    Schlesinger M; Ilfeld D; Handzel ZT; Altman Y; Kuperman O; Levin S; Bibi C; Netzer L; Trainin N
    Clin Exp Immunol; 1983 Oct; 54(1):73-9. PubMed ID: 6225583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of anti-tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and/or sacroiliitis who were resistant to colchicine treatment.
    Bilgen SA; Kilic L; Akdogan A; Kiraz S; Kalyoncu U; Karadag O; Ertenli I; Dogan I; Calguneri M
    J Clin Rheumatol; 2011 Oct; 17(7):358-62. PubMed ID: 21946459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colchicine is a safe drug in children with familial Mediterranean fever.
    Padeh S; Gerstein M; Berkun Y
    J Pediatr; 2012 Dec; 161(6):1142-6. PubMed ID: 22738946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [INTERLEUKIN 1 INHIBITORS--A NEW HORIZON IN THE TREATMENT OF FAMILIAL MEDITERRANEAN FEVER].
    Shouval R; Livneh A; Ben-Zvi I
    Harefuah; 2015 Nov; 154(11):716-9, 741. PubMed ID: 26821505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.